Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study
Novartis
Novartis
Deciphera Pharmaceuticals, LLC
Stanford University
INSYS Therapeutics Inc
University of Alberta
Case Comprehensive Cancer Center